{"name":"Chimagen Biosciences, Ltd","slug":"chimagen-biosciences-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNbWo0OGlzMG9fRkRrRExHeUVDRURPVG40azZtMm84cDM1eGFYMGVKRHNkTE5ONTBGb0p3alRhaS1QYW9tdTVjRjQ0d1pFUGFqdVJCN3JDX0ZtYUFkOVBhWEYwUmhRYmEwckY0cU5uYkhMMXV4eWtSdTM3OWphS2tHbW1RYUpCQXZiWnRISXFjTHRqTV9MSmY3U1dSSksxNlBSSHZvWW9JdjhRdm5vV19KTFZLTHVWZw?oc=5","date":"2024-11-05","type":"deal","source":"PMLiVE","summary":"GSK expands immunology pipeline by acquiring Chimagen’s CMG1A46 in deal worth $850m - PMLiVE","headline":"GSK expands immunology pipeline by acquiring Chimagen’s CMG1A46 in deal worth $850m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNdmY5azBENHRVYy1CekdWQ045Sks3RkNFTk9tMFNjSTZDcFE2ZnhMeFRMSDRQM1BoVzhRWUh1QUx3SkJYOElPT3ZlemtnaGJ6QVBaM0g5UGpnRkFUb2MzOE9wWS1KcHNUN0VWa0xlcTlBblNvZGxtX3kwRXlNcWFVbW8zNlRRdGpLc1BSRHRXNC1ndXVCeXVxc1ZaR1pwOG41aEl1RE5xWm9Kd0d6NFIwNFVLVQ?oc=5","date":"2024-10-29","type":"deal","source":"GSK","summary":"GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline - GSK","headline":"GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPSWRFNmJLQTYtNFJXTEhfbzFkWkNFaktUQ1dpSmltMmI1N1NYQWk3RWRBd0pYRE5pUDl4SGFsbl9PYUg5Y01CMnFGcVlUZlUxRkZWVVZ4U0pTbFJoYlB6WC1ETkFQSHJSU2p6SHdLX1c5emhlcUl1dkotVUNrbV9qVjFmc0NTNFBTdTlKcjNtYXBVa1BTRlE?oc=5","date":"2024-10-29","type":"deal","source":"BioPharma Dive","summary":"GSK to pay $300M to license drug it sees as potential lupus treatment - BioPharma Dive","headline":"GSK to pay $300M to license drug it sees as potential lupus treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1rV3VyVkZXbzRYUVp2NlRUdTVPdDFPWE9UNV9FVVFLYV8zVU9JNW5USGVQYy02czhIaXlISnBNdkR0Zzd2eE1xWVlxMGxTamRRTWwyVkp6Y2JWcWw2eFE?oc=5","date":"2023-06-25","type":"deal","source":"Cooley","summary":"Yiming Liu - Partner in Charge – Shanghai - Cooley","headline":"Yiming Liu - Partner in Charge – Shanghai","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}